Predicting chemotherapy toxicity and death in older adults with colon cancer: Results of MOST (Massilia Oncologic Senior Tests) study.

被引：2
|
作者：
Retornaz, Frederique
Guillem, Olivier
Gholam, Dany
Codoul, Jean-Francois
Brativesic, Cecile
Morvan, Francois
Rinaldi, Yves
Barriere, Nicolas
Nahon, Sophie
Butaud, Chantal
Guerin, Olivier
Boulahssass, Rabia
Grino, Michel
Rousseau, Frederique
机构：
[1] Ctr Gerontol Marseille, Marseille, France
[2] GHI ALPES SUD, Gap, France
[3] Ctr Hosp Dracenie, Draguignan, France
[4] CH Dracenie, Pole Cancerol, Draguignan, France
[5] Inst Paoli Calmettes, Marseille, France
[6] Serv D Oncol Med, Pontoise, France
[7] Hop Europeen, Marseille, France
[8] Ctr Hosp Aix Provence, Aix En Provence, France
[9] Ctr Hosp Toulon, Toulon, France
[10] Univ Cote Azur, Cimiez Hosp, Dept Geriatr Med, FHU Oncoage, Nice, France
[11] FHU ONCOAGE, Nice, France
[12] Ctr Gerontol Dept Marseille, Marseille, France
[13] Paoli Calmettes Inst, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.10041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10041
引用
收藏
页数：2
相关论文
共 35 条
  • [31] Pilot study of the implementation of G8 screening tool, cognitive screening assessment and chemotherapy toxicity assessment in older adults with cancer in a tertiary University Hospital in Ireland.
    AlSendi, Maha
    Flynn, Calvin
    Khan, Muhammad Raheel
    Selvadurai, Paul
    Crown, John
    McDermott, Raymond S.
    Walshe, Janice Maria
    Fennelly, David William
    Hanrahan, Emer O.
    Doherty, Mark
    Higgins, Michaela Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Phase II results of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA) phase II/III study.
    Morris, Van K.
    Yothers, Greg
    Kopetz, Scott
    Puhalla, Shannon L.
    Lucas, Peter C.
    Iqbal, Atif
    Boland, Patrick M.
    Deming, Dustin A.
    Scott, Aaron J.
    Lim, Howard J.
    Jacobs, Samuel A.
    Hong, Theodore S.
    Wolmark, Norman
    George, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 5 - 5
  • [33] The performance of three oncogeriatric screening tools-G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study
    Kotzerke, David
    Moritz, Falk
    Mantovani, Luisa
    Hambsch, Peter
    Hering, Kathrin
    Kuhnt, Thomas
    Yahiaoui-Doktor, Maryam
    Forstmeyer, Dirk
    Lordick, Florian
    Knoedler, Maren
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (06) : 937 - 943
  • [34] Quality of life, blood transfusions, and toxicity, in anemic patients with advanced cancer receiving weekly erythropoietin while on chemotherapy: Results from a phase III randomized double-blind placebo-controlled study.
    Sloan, JA
    Witzig, T
    Silberstein, P
    Novotny, PJ
    Allred, JB
    Baker, BA
    Loprinzi, CL
    BLOOD, 2002, 100 (11) : 287A - 287A
  • [35] Evaluation of the geriatric 8 (G8) screening tool in a multi-ethnic Asian population of older adults with cancer: Results from Geriatric Oncology Longitudinal End to eNd (GOLDEN) Study.
    Chen, Matthew Zhixuan
    Rais, Nydia Camelia
    Tey, Jeremy Chee Seong
    Ling, Natalie Mun Wai
    Ng, Yean Shin
    Chun, Meiling
    Said, Noorhanah Mohd
    Eng, Wan Nghee
    Ho, Francis
    Pang, Shien Ling Angela
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
1234